Prostate Cancer - Results from #28140

Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1 - Abstract April 28, 2011

Image-guided radiotherapy for prostate cancer: A prospective trial of concomitant boost using Indium-111-capromab pendetide (ProstaScint) imaging - Abstract April 28, 2011

EAU 2011 - A negative multi-parametric MRI can rule out up to 97% of clinically significant prostate cancer - Session Highlights April 28, 2011

EAU 2011 - Exponential PSA trends predict the risk of high Gleason cancer two years into the future for a screening population - Session Highlights April 28, 2011

High-risk prostate cancer: The role of radical prostatectomy for local therapy - Abstract April 27, 2011

Predictive factors for prostate cancer in biopsy of patients with prostate-specific antigen levels equal to or less than 4 ng/ml - Abstract April 27, 2011

Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells - Abstract April 27, 2011

Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer - Abstract April 27, 2011

Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study - Abstract April 27, 2011

Inguinal hernia after radical retropubic prostatectomy: Risk factors and prevention - Abstract April 27, 2011

Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaidTM: Mechanism of activity - Abstract April 27, 2011

Cost effectiveness of zoledronic acid in the management of skeletal metastases in hormone-refractory prostate cancer patients in France, Germany, Portugal, and the Netherlands - Abstract April 27, 2011

New prostate cancer test gives more accurate diagnosis April 27, 2011

EAU 2011 - Does the increasing life expectancy translate into decreasing competing mortality rates after radical prostatectomy? - Session Highlights April 27, 2011

EAU 2011 - Is 10-year follow-up long enough to evaluate oncological outcomes of patients after radical prostatectomy? - Session Highlights April 27, 2011

EAU 2011 - Cosmetic outcome after radical prostatectomy: A patient’s preference survey - Session Highlights April 27, 2011

EAU 2011 - Impact of surgical technique (open vs. laparoscopic vs. robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: An analysis using propensity score matching - Session Highlights April 27, 2011

Active surveillance program for prostate cancer: An update of the Johns Hopkins Experience - Abstract April 26, 2011

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: Meta-analysis of Radiation Therapy Oncology Group trials - Abstract April 26, 2011

Androgen deprivation therapy and morbid obesity: Do they share cardiovascular risk through metabolic syndrome? - Abstract April 26, 2011

Page 1408 of 1436